Advisor Group Holdings, Inc. Lipocine Inc. Transaction History

Advisor Group Holdings, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.73 - $1.34 $255 - $469	-350 Reduced 23.33%	1,150 $1,000
Q1 2022 May 04, 2022	SELL	$0.89 - $1.85 $13,172 - $27,380	-14,800 Reduced 90.8%	1,500 $2,000
Q1 2021 May 13, 2021	BUY	$1.38 - $2.28 $3,449 - $5,699	2,500 Added 18.12%	16,300 $25,000
Q1 2020 May 18, 2020	BUY	$0.32 - $0.77 $4,416 - $10,626	13,800 New	13,800 $7,000

Ticker LPCN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,510,800
Market Cap $418M
Description
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.